MADISON, N.J., July 18, 2017 /PRNewswire/ -- Quest
Diagnostics (NYSE: DGX) today announced that it has completed its
previously announced acquisition of the laboratory businesses Med
Fusion and Clear Point. Operating from a nearly 200,000 square
foot facility in Lewisville,
Texas, the two businesses form the basis for the company's
first national center of excellence in precision diagnostics for
oncology.
In connection with the transaction, Quest is now a preferred
provider to several organizations that are formerly owners of
one or both of these businesses. These organizations include
Baylor Scott & White Health
(BSWH), The US Oncology Network (The Network), Texas Oncology, and
Pathologists Bio-Medical Laboratories. Specifically, Quest will
provide services on a preferred basis to 12 hospitals of BSWH in
North Texas and 1,400 independent,
community-based physicians nationally that are affiliated with The
Network, including Texas Oncology. The Network is supported by
McKesson Specialty Health, a division of McKesson Corporation.
In addition, Quest Diagnostics will collaborate with McKesson
Specialty Health, The Network and Texas Oncology to enhance and
nationally scale a model created by Med Fusion that standardizes
next-generation gene sequencing panels to aid therapy selection and
monitoring for cancer. This approach guides the physician, within
an electronic health record, to a panel individualized according to
guidelines to the patient's cancer type and stage of disease.
For patients with cancer, precision diagnostics, such as genomic
sequencing of a tumor's DNA, may help a physician select a therapy
or clinical trial and monitor response.
About Quest Diagnostics
Quest Diagnostics empowers
people to take action to improve health outcomes. Derived
from the world's largest database of clinical lab results, our
diagnostic insights reveal new avenues to identify and treat
disease, inspire healthy behaviors and improve health care
management. Quest annually serves one in three adult
Americans and half the physicians and hospitals
in the United States, and our 43,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform lives. For more
information, please visit www.QuestDiagnostics.com.
50th Anniversary: In 2017, Quest Diagnostics celebrates 50 years
of life-changing results. To learn about our legacy of
accomplishments and quest to improve healthcare in the future,
visit www.QuestDiagnostics.com/50Years.
View original content with
multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-completes-acquisition-of-med-fusion-and-clear-point-in-texas-forming-national-precision-oncology-center-of-excellence-300489388.html
SOURCE Quest Diagnostics